Getty Images/Futurism



Building on the growing body of work surrounding “magic mushrooms” that produce the psychoactive compound psilocybin, a new study suggests that just one dose of a synthetically-made version can help ease the worst symptoms of depression.

Published in the New England Journal of Medicine, the findings from this randomized and double-blind clinical trial — which the study authors call “the largest of its kind” — are pretty, well, trippy.

That "Research" About How Smartphones Are Causing Deformed Human Bodies Is SEO Spam, You Idiots
Jeff Bezos' Housekeeper Says She Had to Climb Out the Window to Use the Bathroom
Hackers Just Took Down One of the World's Most Advanced Telescopes
AOC Says Her Twitter Account Broke After She Made Fun of Elon Musk
Huge Drone Swarm to Form Giant Advertisement Over NYC Skyline




The synthetic psilocybin is called “COMP360” by its creator, Dr. Guy Goodwin, who serves as both as an Oxford University professor emeritus of psychiatry and as chief medical officer of COMPASS Pathways, which manufactures the compound, CNN notes in a writeup of the study.

“This drug can be extracted from magic mushrooms, but that is not the way our compound is generated,” Goodwin told CNN. “It’s synthesized in a purely chemical process to produce a crystalline form.”

While COMP360 is not the same thing as eating stems or crushed up mushrooms inside a large DIY pill capsule, its effects appear to be similar — including the post-trip afterglow, which the researchers described as being highest the day after taking the 25 milligram dosage.

Every participant in the 233-person study, which was conducted at 22 sites in the United States, the United Kingdom, and Canada, had treatment-resistant depression, a diagnosis given when an individual doesn’t respond to two or more types of antidepressant medication. All who were on antidepressants were advised to taper off of their medicine prior to the trial because these medications can counteract the benefits of psychedelics, though they were able to go back on them if necessary, CNN noted.

Depression levels in the participants were measured just before their “trips” and then at various points in the days and weeks after. The results were striking: the researchers found that overall, 37 percent of the trial patients experienced an improvement in symptoms and 29 percent were even “in remission” three weeks after the study.

“The maximum effect (was) seen the day after receiving the treatment,” Dr. Anthony Cleare, a psychopharmacology professor at King’s College London who was not involved in the study, told CNN. “This contrasts with standard antidepressants, which take several weeks to reach maximum effect.”

Something unfortunate seemed to happen around 12 weeks after the treatment, however: those who experienced an easing of their depression symptoms said it began to return.

“The effects did start to wear off by three months, and we need to know how best to prevent the depression returning,” Cleare said.

As Dr. Ravi Das, an associate professor of educational psychology at University College London who was also not involved in the study told CNN, “this is not a spectacular response rate for a psychiatric treatment… and we would only expect this to worsen over a longer follow-up period.”

There’s obviously much more research that needs to be done to determine the dosage and frequency of these sorts of treatments — which both boosters and detractors admitted in CNN‘s interviews — to figure out how to fine-tune it as an alternative form of depression treatment and mitigate the classic psilocybin side effects, which include nausea and dizziness.

Nevertheless, this large, first-of-its-kind study has huge implications for the power of psychedelic mental health treatment, and the backing of storied institutions like Oxford and the NEJM to boot.

More on psychedelics: Elon Musk Has Reportedly Been Telling Friends About Benefits of Shrooms and MDMA

About michelleclarke2015

Life event that changes all: Horse riding accident in Zimbabwe in 1993, a fractured skull et al including bipolar anxiety, chronic fatigue …. co-morbidities (Nietzche 'He who has the reason why can deal with any how' details my health history from 1993 to date). 17th 2017 August operation for breast cancer (no indications just an appointment came from BreastCheck through the Post). Trinity College Dublin Business Economics and Social Studies (but no degree) 1997-2003; UCD 1997/1998 night classes) essays, projects, writings. Trinity Horizon Programme 1997/98 (Centre for Women Studies Trinity College Dublin/St. Patrick's Foundation (Professor McKeon) EU Horizon funded: research study of 15 women (I was one of this group and it became the cornerstone of my journey to now 2017) over 9 mth period diagnosed with depression and their reintegration into society, with special emphasis on work, arts, further education; Notes from time at Trinity Horizon Project 1997/98; Articles written for Irishhealth.com 2003/2004; St Patricks Foundation monthly lecture notes for a specific period in time; Selection of Poetry including poems written by people I know; Quotations 1998-2017; other writings mainly with theme of social justice under the heading Citizen Journalism Ireland. Letters written to friends about life in Zimbabwe; Family history including Michael Comyn KC, my grandfather, my grandmother's family, the O'Donnellan ffrench Blake-Forsters; Moral wrong: An acrimonious divorce but the real injustice was the Catholic Church granting an annulment – you can read it and make your own judgment, I have mine. Topics I have written about include annual Brain Awareness week, Mashonaland Irish Associataion in Zimbabwe, Suicide (a life sentence to those left behind); Nostalgia: Tara Hill, Co. Meath.
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s